Cost-Benefit Analysis

Author:

Anthony E. Boardman

Publisher:

Cambridge University Press

Rs2945 Rs5354 45% OFF

Availability: Available

Shipping-Time: Same Day Dispatch

    

Rating and Reviews

0.0 / 5

5
0%
0

4
0%
0

3
0%
0

2
0%
0

1
0%
0
Publisher

Cambridge University Press

Publication Year 2018
ISBN-13

9781108401296

ISBN-10 9781108401296
Binding

Paperback

Number of Pages 520 Pages
Language (English)
Dimensions (Cms) 19.05 x 2.57 x 24.77
Weight (grms) 1102
Cost-Benefit Analysis provides accessible, comprehensive, authoritative, and practical treatments of the protocols for assessing the relative efficiency of public policies. Its review of essential concepts from microeconomics, and its sophisticated treatment of important topics with minimal use of mathematics helps students from a variety of backgrounds build solid conceptual foundations. It provides thorough treatments of time discounting, dealing with contingent uncertainty using expected surpluses and option prices, taking account of parameter uncertainties using Monte Carlo simulation and other types of sensitivity analyses, revealed preference approaches, stated preference methods including contingent valuation, and other related methods. Updated to cover contemporary research, this edition is considerably reorganized to aid in student and practitioner understanding, and includes eight new cases to demonstrate the actual practice of cost-benefit analysis. Widely cited, it is recognized as an authoritative source on cost-benefit analysis. Illustrations, exhibits, chapter exercises, and case studies help students master concepts and develop craft skills.

Anthony E. Boardman

Anthony E. Boardman is a professor at the University of British Columbia, Vancouver. With colleagues, he has won the Peter Larkin Award, the Alan Blizzard Award, the John Vanderkamp prize, and the J. E. Hodgetts Award. He has also been a consultant to many leading public sector and private sector organisations, including the Government of Canada and the Inter-American Development Bank. He served two terms on the Patented Medicine Prices Review Board and is currently on the Board of the Institute for Health System Transformation and Sustainability.
No Review Found